UPC — Universe Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapContrarian

Annual balance sheet for Universe Pharmaceuticals, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2019 September 30th	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	20-F	20-F	20-F
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	3.18	10.1	21.8	18.9	18.5
Net Total Accounts Receivable
Net Total Receivables	6.42	10.9	15.6	15.2	10.7
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	12.2	23.3	50.5	41.5	36.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.57	4.43	15.4	13.6	12.8
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	17.8	28.8	70.1	59.5	53.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	5.45	8	11.2	13.1	13.8
Total Long Term Debt
Total Debt
Total Liabilities	5.45	8	11.2	13.1	13.8
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	12.4	20.8	58.9	46.4	39.5
Total Liabilities & Shareholders' Equity	17.8	28.8	70.1	59.5	53.3
Total Common Shares Outstanding